Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will open a new 20,000-square-foot cGMP facility in Belgium and add an additional 10,000 square feet at their existing facility in Waterford, Ireland. The expansions will be completed in the first half of 2023.
Novavax, a US-based biopharmaceutical company, and Siegfried have decided to extend their collaboration for the aseptic fill & finish of Novavax's protein-based coronavirus vaccine Nuvaxovid at Siegfried's manufacturing site in Hameln (Germany). The original manufacturing and supply agreement has started in 2021 with an original term until end of 2022 and has now been extended until the end of 2023.
Ecovadis is one of the world's leading providers of trusted business sustainability ratings.This award recognizes MFG's continued commitment to environmental, social, and ethical performance.
